Synthesis of new ferulic/lipoic/comenic acid-melatonin hybrids as antioxidants and Nrf2 activators via Ugi reaction

Aim: Oxidative stress has been implicated in the pathogenesis of many neurodegenerative diseases, and particularly in Alzheimer's disease. Results: This work describes the Ugi multicomponent synthesis, antioxidant power and Nrf2 pathway induction in antioxidant response element cells of (E)-N-(2-((2-(1H-indol-3-yl)ethyl)amino)-2-oxoethyl)-N-(2-(5-(benzyloxy)-1H-indol-3-yl)ethyl)-3-(4-hydroxy-3-methoxyphenyl)acryl amides 8a-d, N-(2-((2-(1H-indol-3-yl)ethyl)amino)-2-oxoethyl)-N-(2-(5-(benzyloxy)-1H-indol-3-yl)ethyl)-5-(1,2-dithiolan-3-yl)pentanamides 8e-h and N-(2-((2-(1H-indol-3-yl)ethyl)amino)-2-oxoethyl)-N-(2-(5-(benzyloxy)-1H-indol-3-yl)ethyl)-5-hydroxy-4-oxo-4H-pyran-2-carboxamides 8i,j. Conclusion: We have identified compounds 8e and 8g, showing a potent antioxidant capacity, a remarkable neuroprotective effect against the cell death induced by H2O2 in SH-SY5Y cells, and a performing activation of the Nrf2 signaling pathway, as very interesting new antioxidant agents for pathologies that curse with oxidative stress.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Future medicinal chemistry - 11(2019), 24 vom: 21. Dez., Seite 3097-3108

Sprache:

Englisch

Beteiligte Personen:

Pachón-Angona, Irene [VerfasserIn]
Martin, Helène [VerfasserIn]
Chhor, Stecy [VerfasserIn]
Oset-Gasque, María-Jesús [VerfasserIn]
Refouvelet, Bernard [VerfasserIn]
Marco-Contelles, José [VerfasserIn]
Ismaili, Lhassane [VerfasserIn]

Links:

Volltext

Themen:

73Y7P0K73Y
ARE cells
AVM951ZWST
Antioxidants
BBX060AN9V
Carboxylic Acids
Comenic acid
Coumaric Acids
Ferulic acid
Hydrogen Peroxide
JL5DK93RCL
Journal Article
Melatonin
NF-E2-Related Factor 2
NFE2L2 protein, human
Neuroprotective Agents
Nrf2 pathway
ORAC
Pyrones
Research Support, Non-U.S. Gov't
Thioctic Acid
Ugi multicomponent reaction

Anmerkungen:

Date Completed 10.07.2020

Date Revised 10.07.2020

published: Print

Citation Status MEDLINE

doi:

10.4155/fmc-2019-0191

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM304399647